Have your own idea? Try our Stock Screener
Japanese (NIKKEI) Biotech Industry Analysis
UpdatedFeb 26, 2026
DataAggregated Company Financials
Companies34
- 7D-3.0%
- 3M7.2%
- 1Y5.8%
- YTD19.0%
Over the last 7 days, the Biotech industry has dropped 2.0%, driven by Cuorips declining 39%. Meanwhile, GNI Group actually outperformed within the industry, gaining 7.1% in the last week. This takes the industry's 12 month performance to a gain of 4.1%. As for the next few years, earnings are expected to grow by 43% per annum.
Industry Valuation and Performance
Has the Japanese Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 26 Feb 2026 | JP¥1.2t | JP¥200.5b | -JP¥50,373,794,682.00 | 296.3x | -23.9x | 6x |
| Sat, 24 Jan 2026 | JP¥1.1t | JP¥198.7b | -JP¥70,406,297,000.00 | 66x | -16.2x | 5.7x |
| Mon, 22 Dec 2025 | JP¥953.3b | JP¥198.7b | -JP¥70,727,642,000.00 | 53.9x | -13.5x | 4.8x |
| Wed, 19 Nov 2025 | JP¥1.1t | JP¥196.3b | -JP¥69,295,824,000.00 | 50.7x | -15.3x | 5.4x |
| Fri, 17 Oct 2025 | JP¥1.2t | JP¥197.7b | -JP¥65,502,425,000.00 | 63.6x | -17.7x | 5.8x |
| Sun, 14 Sep 2025 | JP¥1.2t | JP¥197.7b | -JP¥66,398,866,000.00 | 67.6x | -17.9x | 6x |
| Tue, 12 Aug 2025 | JP¥1.2t | JP¥191.4b | -JP¥67,467,768,000.00 | 128x | -17.6x | 6.2x |
| Thu, 10 Jul 2025 | JP¥1.1t | JP¥218.2b | -JP¥43,671,220,000.00 | 99x | -24.8x | 5x |
| Sat, 07 Jun 2025 | JP¥1.2t | JP¥214.8b | -JP¥40,595,705,000.00 | 14.7x | -29.7x | 5.6x |
| Mon, 05 May 2025 | JP¥1.1t | JP¥207.8b | -JP¥39,129,850,000.00 | 15x | -27.5x | 5.2x |
| Wed, 02 Apr 2025 | JP¥1.0t | JP¥207.8b | -JP¥39,285,612,000.00 | 15.5x | -26x | 4.9x |
| Fri, 28 Feb 2025 | JP¥1.1t | JP¥207.4b | -JP¥38,725,942,000.00 | 15.4x | -27.2x | 5.1x |
| Sun, 26 Jan 2025 | JP¥994.6b | JP¥207.3b | -JP¥13,514,452,000.00 | 20.8x | -73.6x | 4.8x |
| Tue, 24 Dec 2024 | JP¥1.0t | JP¥206.4b | -JP¥12,718,809,000.00 | 22.7x | -82.5x | 5.1x |
| Thu, 21 Nov 2024 | JP¥1.0t | JP¥207.5b | -JP¥10,836,549,000.00 | 19.4x | -94.7x | 4.9x |
| Sat, 19 Oct 2024 | JP¥1.1t | JP¥214.3b | -JP¥3,941,502,000.00 | 21.8x | -285.1x | 5.2x |
| Mon, 16 Sep 2024 | JP¥1.0t | JP¥210.1b | -JP¥469,229,000.00 | 18.5x | -2218.2x | 5x |
| Wed, 14 Aug 2024 | JP¥971.5b | JP¥213.8b | JP¥1.9b | 13.4x | 519.7x | 4.5x |
| Fri, 12 Jul 2024 | JP¥1.1t | JP¥187.7b | -JP¥15,773,047,000.00 | 93.7x | -67.5x | 5.7x |
| Sun, 09 Jun 2024 | JP¥828.3b | JP¥195.7b | -JP¥14,113,284,000.00 | 96.5x | -58.7x | 4.2x |
| Tue, 07 May 2024 | JP¥802.6b | JP¥199.1b | -JP¥14,617,545,000.00 | 77.4x | -54.9x | 4x |
| Thu, 04 Apr 2024 | JP¥745.3b | JP¥194.2b | -JP¥15,456,803,000.00 | 61.3x | -48.2x | 3.8x |
| Sat, 02 Mar 2024 | JP¥814.8b | JP¥196.2b | -JP¥19,179,997,000.00 | 65.5x | -42.5x | 4.2x |
| Mon, 29 Jan 2024 | JP¥779.2b | JP¥222.3b | -JP¥12,604,827,000.00 | 17.6x | -61.8x | 3.5x |
| Wed, 27 Dec 2023 | JP¥773.1b | JP¥224.2b | -JP¥12,970,409,000.00 | 16.3x | -59.6x | 3.4x |
| Fri, 24 Nov 2023 | JP¥787.4b | JP¥221.9b | -JP¥12,426,487,000.00 | 17.2x | -63.4x | 3.5x |
| Sun, 22 Oct 2023 | JP¥741.7b | JP¥223.0b | -JP¥14,478,735,000.00 | 20.5x | -51.2x | 3.3x |
| Tue, 19 Sep 2023 | JP¥875.3b | JP¥223.0b | -JP¥14,518,735,000.00 | 27.6x | -60.3x | 3.9x |
| Thu, 17 Aug 2023 | JP¥860.0b | JP¥225.1b | -JP¥16,853,776,000.00 | 49.5x | -51x | 3.8x |
| Sat, 15 Jul 2023 | JP¥927.2b | JP¥223.0b | -JP¥19,224,669,000.00 | 53.5x | -48.2x | 4.2x |
| Mon, 12 Jun 2023 | JP¥967.6b | JP¥220.6b | -JP¥21,578,670,000.00 | 46.3x | -44.8x | 4.4x |
| Wed, 10 May 2023 | JP¥925.0b | JP¥218.2b | -JP¥20,061,938,000.00 | 21.3x | -46.1x | 4.2x |
| Fri, 07 Apr 2023 | JP¥911.9b | JP¥218.3b | -JP¥21,583,164,000.00 | 21.5x | -42.3x | 4.2x |
| Sun, 05 Mar 2023 | JP¥923.3b | JP¥216.2b | -JP¥18,991,580,000.00 | 20.7x | -48.6x | 4.3x |
Price to Earnings Ratio
-48.6x
Current Industry PE
- Investors are optimistic on the Japanese Biotechs industry, and appear confident in long term growth rates.
- The 3-year average PS ratio of 4.7x is lower than the industry's current PS ratio of 5.8x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have deteriorated over the last three years.
- Revenues have also declined 2.5% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Trends
Which industries have driven the changes within the Japanese Healthcare industry?
| JP Market | 1.00% | |
| Healthcare | 3.19% | |
| Biotech | -3.00% | |
| Biotech | -3.00% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 2160 GNI Group | JP¥2.97k | 7.1% +JP¥11.0b | -20.5% | PS6.2x | |
| 4588 Oncolys BioPharma | JP¥2.71k | 10.5% +JP¥7.6b | 292.5% | PS2777.1x | |
| 7774 Japan Tissue Engineering | JP¥700.00 | 12.2% +JP¥3.1b | 40.3% | PS12.6x | |
| 4978 ReproCELL | JP¥183.00 | 9.6% +JP¥1.5b | 0% | PS6.9x | |
| 4587 PeptiDream | JP¥1.40k | 0.7% +JP¥1.3b | -32.0% | PS9.8x |
